Genisi, LIFC's xenoderm product, in preparation for release as early as late this year will provide just that. They key to the success of their product is the success of their decellularization process. The "wash" is apparently very gentle to the underlying intracellular matrix, and if it works as well with pig skin as it has with human skin, the product will dominate the market.
Wright med. has already filed suit to block Xenoderm, but it is likely a groundless attempt as the key to the product is the wash.
aj
News 
Market Data 
Discover 
